Covered recipient · General Payments record
AMY N HEAD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,869.72
- Reported across 78 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $994.71 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $207.75 | 3 |
| ABBVIE INC. | $204.26 | 11 |
| Phathom Pharmaceuticals, Inc. | $149.08 | 2 |
| GENZYME CORPORATION | $120.58 | 1 |
| Novo Nordisk AS | $71.39 | 3 |
| Amgen Inc. | $67.61 | 4 |
| Lilly USA, LLC | $55.29 | 3 |
| PFIZER INC. | $32.82 | 2 |
| IDORSIA PHARMACEUTICALS US INC | $18.73 | 1 |
| Astellas Pharma US Inc | $17.85 | 1 |
| Exact Sciences Corporation | $16.89 | 1 |
| Tris Pharma Inc | $16.36 | 1 |
| GlaxoSmithKline, LLC. | $16.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $15.52 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125042328 | CMS |
| Abbott Laboratories | $16.32 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125042330 | CMS |
| Abbott Laboratories | $175.91 | 12/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125042332 | CMS |
| ABBVIE INC. | $7.50 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310439 | CMS |
| ABBVIE INC. | $13.05 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310441 | CMS |
| ABBVIE INC. | $107.14 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310443 | CMS |
| ABBVIE INC. | $6.86 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310445 | CMS |
| ABBVIE INC. | $17.01 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310447 | CMS |
| ABBVIE INC. | $3.41 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310449 | CMS |
| ABBVIE INC. | $10.00 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310451 | CMS |
| ABBVIE INC. | $14.40 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310453 | CMS |
| ABBVIE INC. | $3.00 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310455 | CMS |
| ABBVIE INC. | $6.92 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310457 | CMS |
| ABBVIE INC. | $14.97 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310459 | CMS |
| Amgen Inc. | $15.35 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117575592 | CMS |
| Amgen Inc. | $16.31 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115711532 | CMS |
| Amgen Inc. | $16.64 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117575594 | CMS |
| Amgen Inc. | $19.31 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115711538 | CMS |
| Astellas Pharma US Inc | $17.85 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139466282 | CMS |
| Exact Sciences Corporation | $16.89 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114535256 | CMS |
| GENZYME CORPORATION | $120.58 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139864670 | CMS |
| GlaxoSmithKline, LLC. | $16.10 | 11/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116225407 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $18.73 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146764230 | CMS |
| Lilly USA, LLC | $21.30 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135496904 | CMS |
| Lilly USA, LLC | $18.62 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135507888 | CMS |
| Lilly USA, LLC | $15.37 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135496906 | CMS |
| Novo Nordisk Inc | $38.97 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100365983 | CMS |
| Novo Nordisk Inc | $14.89 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100523039 | CMS |
| Novo Nordisk Inc | $17.53 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100647567 | CMS |
| PFIZER INC. | $15.59 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132121560 | CMS |
| PFIZER INC. | $17.23 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131026076 | CMS |
| Phathom Pharmaceuticals, Inc. | $20.97 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151172864 | CMS |
| Phathom Pharmaceuticals, Inc. | $128.11 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151172866 | CMS |
| Tris Pharma Inc | $16.36 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147202379 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.